TECH vs TMCI · P/E 65, rev $1.22B vs rev $209.4M
Bio-Techne Corp (TECH) versus Treace Medical Concepts Inc (TMCI) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TMCI revenue for 2024-12-31 was $209.4M. Net income was -$55.7M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. TMCI currently screens at market cap $260.1M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TMCI currently screens at market cap $260.1M.
Not investment advice. Open the TECH and TMCI stock pages for the full models.
Not investment advice.